Answers are grounded in this paper and cite their sources.
This was not an industry supported study. Dr. Bonnet has received research support from Neurocrine, Pfizer, and Cephalon; and serves on the board or participates in speaking arrangements supported by the Sleep Medicine Educational Institute, Sanofi-Aventis, and Takeda. Dr. Dinges has received research support from Cephalon, and Mars-Masterfoods, Inc.; is a paid consultant for Pfizer, Takeda, Merck, Aventis, and Sanofi; and has received speaker honoraria from and serves on the advisory board for Cephalon. Dr. Roehrs has participated in speaking engagements supported by Sepracor; and is a consultant for Sepracor and Sanofi. Dr. Rogers has received research support from Cephalon. Drs. Balkin and Wesensten have indicated no financial conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Bonnet et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: